Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Little information exists regarding Ebola vaccine rVSVΔG-ZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18–24 weeks postenrollment) vaccination. Pregnancy was an exclusion criterion, but...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Emerg Infect Dis
Hlavní autoři: Legardy-Williams, Jennifer K., Carter, Rosalind J., Goldstein, Susan T., Jarrett, Olamide D., Szefer, Elena, Fombah, Augustin E., Tinker, Sarah C., Samai, Mohamed, Mahon, Barbara E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Centers for Disease Control and Prevention 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7045819/
https://ncbi.nlm.nih.gov/pubmed/32017677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2603.191018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky